Rite Aid Allergy & Congestion Tablets Fail Dissolution Specifications
Rite Aid Pharmacy is recalling Allergy & Congestion extended-release tablets because two lots failed to meet dissolution specifications. The affected product was distributed nationwide.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: This is an FDA Class III recall for a manufacturing defect (failed dissolution specifications) with no reported illnesses or injuries. Per the rubric, FDA Class III recalls are typically scored 1 or 2; absent any evidence of actual harm, the score is 1.
Plain-English summary
Rite Aid Pharmacy is recalling Allergy & Congestion, Fexofenadine HCl 60mg & Pseudoephedrine HCl 120mg, Extended Release Tablets USP in 20-tablet boxes (UPC 011822738873) due to failed dissolution specifications. The manufacturer, Dr. Reddy's Laboratories, Inc., identified that certain lots did not dissolve properly according to required standards.
Two specific lots are affected: Lot #AC2103330D (Expiration 1/31/2023) and Lot #AC2106452E (Expiration 3/31/2023). Approximately 7,080 boxes were distributed nationwide in the USA by Rite Aid, 30 United Lane, Camp Hill, PA 17011. The tablets were manufactured in India.
Consumers who have purchased this product and have the affected lot numbers should stop using them and contact their pharmacy or healthcare provider for guidance. Consumers may also contact Dr. Reddy's Laboratories customer service or return the product to the place of purchase.
The recalled product
- Product
- Rite Aid Pharmacy, Allergy & Congestion, Fexofenadine HCl 60mg & Pseudoephedrine HCl 120mg, Extended Release Tablets USP, 20 Extended-Release Tablets per box, UPC 011822738873, Distributed by Rite Aid, 30 United Lane, Camp Hill, PA 17011, Made in India.
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Hazard
- dissolution-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: AC2103330D
- Exp.1/31/2023
- AC2106452E
- Exp. 3/31/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27